Effectiveness of Pain Neuroscience Education in Rotator Cuff Related Shoulder Pain
Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Nov 5, 2024
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a special education program about pain, called pain neuroscience education, combined with exercise for people suffering from rotator cuff related shoulder pain. The goal is to see if this approach can help reduce pain, improve daily activities, and enhance overall quality of life for individuals experiencing shoulder issues like impingement syndrome and tendinopathy.
To participate in this study, individuals need to be between 40 and 65 years old and have experienced shoulder pain for at least three months. They should have specific signs of shoulder problems, like pain during certain movements, and a pain level between 3 and 7 on a scale where 10 is the worst pain imaginable. Participants can expect to learn more about their pain and how it relates to their condition, alongside engaging in exercise. The trial is currently recruiting, and anyone interested should check for eligibility and further details.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being aged between 40 and 65 years
- • Presence of shoulder pain for at least 3 months
- • At least one positive finding in each of the following categories; 1) Painful arc finding during flexion or abduction, 2) Positive Neer's or Kennedy-Hawkins Tests, 3) Pain with resisted external rotation, abduction or empty can test
- • Pain level of at least 3 and at most 7 according to Visual Analogue Scale (VAS) at rest
- • Being literate
- Exclusion Criteria:
- • Systemic inflammatory shoulder pain
- • Having had a shoulder dislocation or fracture in the last 12 months
- • Having had a shoulder surgery
- • Having received physiotherapy or corticosteroid injection treatment for the shoulder in the last 3 months
- • Presence of adhesive capsulitis (passive shoulder ROM \<50%)
- • Presence of vision and hearing problems
- • Having been diagnosed a disease that may cause neurological-cognitive changes and prevents understanding the content of the ANE program
About Istanbul University Cerrahpasa
Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported